Stephen Webster

(Mr. Stephen Webster)

Currently holds positions in Spark Therapeutics Inc, Adolor Corp, NextCure Inc, TCR2 Therapeutics Inc and Nabriva Therapeutics PLC

Positions

Position Company Period
Chief Financial Officer Spark Therapeutics Inc July 1, 2014 -
Chief Financial Officer, Senior Vice President - Finance Adolor Corp June 23, 2008 -
Independent Director NextCure Inc April 1, 2019 -
Independent Director TCR2 Therapeutics Inc April 30, 2020 -
Independent Member of the Supervisory Board Nabriva Therapeutics PLC Aug. 1, 2016 -
Independent Director Viking Therapeutics Inc May 1, 2014 - May 21, 2020
Stephen Webster's trades of Nabriva Therapeutics PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-08-04 2022-08-02 S Sale
7,826 -40.6%
0.19
USD 1,487
7,826 -40.6% 0.19 USD 1,487
2021-08-04 2021-08-02 S Sale
777 -3.9%
1.20
USD 932
777 -3.9% 1.20 USD 932
2018-05-31 2018-05-29 B Purchase
8,000 +inf%
5.21
USD 41,712
8,000 +inf% 5.21 USD 41,712
// ... existing code ... // ... rest of the file ...